STEVEN THOMPSON: Open Payments
NPI 1659551851 · MOBILE, AL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,610 in 78 payments from 14 companies in 2025. Trend: 2023 $479 · 2024 $1,193 · 2025 $1,610
Food & beverage: $1,610
| Company | Payments | Amount |
|---|---|---|
| Madrigal Pharmaceuticals | 8 | $378 |
| ABBVIE INC. | 25 | $375 |
| Novo Nordisk Inc | 4 | $167 |
| Phathom Pharmaceuticals, Inc. | 12 | $160 |
| Aimmune Therapeutics, Inc. | 10 | $149 |
| Takeda Pharmaceuticals U.S.A., Inc. | 6 | $120 |
| Regeneron Healthcare Solutions, Inc. | 2 | $69 |
| Ardelyx, Inc. | 4 | $65 |
| Janssen Biotech, Inc. | 2 | $37 |
| Amgen Inc. | 1 | $21 |
Products named: REZDIFFRA, Wegovy, VOQUEZNA, ZENPEP, LINZESS, ENTYVIO, CREON, RINVOQ.
Industry payments across AL — which companies pay providers there.
